These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Splanchnic vein thrombosis in myeloproliferative neoplasms. Sekhar M; McVinnie K; Burroughs AK Br J Haematol; 2013 Sep; 162(6):730-47. PubMed ID: 23855810 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis. Yoo EH; Jang JH; Park KJ; Gwak GY; Kim HJ; Kim SH; Kim DK Int J Lab Hematol; 2011 Oct; 33(5):471-6. PubMed ID: 21435189 [TBL] [Abstract][Full Text] [Related]
12. Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms. Giordano G; Napolitano M; Cellurale M; Di Carlo P; Musuraca G; Micucci G; Lucchesi A J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330364 [TBL] [Abstract][Full Text] [Related]
13. [Visceral Vein Thrombosis of Myeloproliferative Neoplasm --Review]. Zhang X; Yang J; Hao HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1627-1630. PubMed ID: 36208278 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms. Pieri L; Paoli C; Arena U; Marra F; Mori F; Zucchini M; Colagrande S; Castellani A; Masciulli A; Rosti V; De Stefano V; Betti S; Finazzi G; Ferrari ML; Rumi E; Ruggeri M; Nichele I; Guglielmelli P; Fjerza R; Mannarelli C; Fanelli T; Merli L; Corbizi Fattori G; Massa M; Cimino G; Rambaldi A; Barosi G; Cazzola M; Barbui T; Vannucchi AM Am J Hematol; 2017 Feb; 92(2):187-195. PubMed ID: 27880982 [TBL] [Abstract][Full Text] [Related]
16. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. De Stefano V; Qi X; Betti S; Rossi E Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms. Arachchillage DR; Laffan M Semin Thromb Hemost; 2019 Sep; 45(6):604-611. PubMed ID: 31382304 [TBL] [Abstract][Full Text] [Related]